Nexalin (NXL) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Nexalin Revenue Highlights


Latest Revenue (Y)

$301.65K

Latest Revenue (Q)

$18.15K

Main Segment (Y)

Device Sales

Main Geography (Y)

CHINA

Nexalin Revenue by Period


Nexalin Revenue by Year

DateRevenueChange
2025-12-31$301.65K78.78%
2024-12-31$168.72K52.35%
2023-12-31$110.75K-91.62%
2022-12-31$1.32M817.20%
2021-12-31$144.06K-40.69%
2020-12-31$242.91K17.13%
2019-12-31$207.38K-

Nexalin generated $301.65K in revenue during NA 2025, up 78.78% compared to the previous quarter, and up 124.18% compared to the same period a year ago.

Nexalin Revenue by Quarter

DateRevenueChange
2025-09-30$18.15K-74.29%
2025-06-30$70.59K72.10%
2025-03-31$41.02K50.91%
2024-12-31$27.18K-24.57%
2024-09-30$36.03K34.24%
2024-06-30$26.84K-65.88%
2024-03-31$78.67K283.09%
2023-12-31$20.54K-14.83%
2023-09-30$24.11K-32.15%
2023-06-30$35.54K16.30%
2023-03-31$30.56K-20.47%
2022-12-31$38.42K-92.95%
2022-09-30$545.32K31.63%
2022-06-30$414.29K28.13%
2022-03-31$323.32K1247.23%
2021-12-31$24.00K-57.12%
2021-09-30$55.97K91.99%
2021-06-30$29.15K-16.57%
2021-03-31$34.94K7.51%
2020-12-31$32.50K-11.93%
2020-09-30$36.91K-57.46%
2020-06-30$86.75K-0.00%
2020-03-31$86.75K-

Nexalin generated $18.15K in revenue during Q3 2025, up -74.29% compared to the previous quarter, and up 67.62% compared to the same period a year ago.

Nexalin Revenue Breakdown


Nexalin Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22
Device Sales$136.00K$55.50K$1.16M-
Equipment$89.04K$37.83K$27.30K$26.78K
Licensing Fee$49.11K$69.50K$82.08K$79.19K
Other$27.49K$5.89K$1.37K$26.41K

Nexalin's latest annual revenue breakdown by segment (product or service), as of Dec 25: Device Sales (45.09%), Equipment (29.52%), Licensing Fee (16.28%), and Other (9.11%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Other$15.89K$7.71K$3.89K$5.51K$288.00$100.00$2.00$270.00$807.00$290.00$275.00$110.00
Equipment$16.70K$52.53K$19.81K$17.51K$18.80K$1.51K$10.62K$5.18K$5.10K$6.40K$4.75K$4.10K
Licensing Fee$31.80K$17.31K$31.00K$16.94K$21.56K$19.51K$18.66K$20.03K$23.87K$18.63K$21.11K-
Licensing fee-$10.36K----------
Device Sales----$55.50K$9.60K-$520.00K----

Nexalin's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Licensing Fee (49.38%), Equipment (25.94%), and Other (24.68%).

Nexalin Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23Dec 22
CHINA$190.30K$85.25K$3.61K$1.21M
UNITED STATES$111.35K$83.47K$107.13K$113.54K

Nexalin's latest annual revenue breakdown by geography, as of Dec 25: CHINA (63.09%), and UNITED STATES (36.91%).

Quarterly Revenue by Country

CountryDec 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
CHINA$110.25K$59.48K$20.57K-$10.21K$14.75K$520.00K-----
UNITED STATES$79.79K$11.11K$20.44K$39.64K$20.66K$23.17K$27.13K$24.11K$25.33K$30.56K$23.68K$25.32K

Nexalin's latest quarterly revenue breakdown by geography, as of Dec 25: CHINA (58.01%), and UNITED STATES (41.99%).

Nexalin Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
HBIOHarvard Bioscience$86.55M$20.59M
SCYXSCYNEXIS$20.60M$1.36M
CLGNCollPlant Bio$10.96M$98.00K
NXLNexalin$301.65K$18.15K
XCURExicure--
IINNInspira Technologies Oxy B.H.N.--
ENLVEnlivex Therapeutics--
MODDModular Medical--
RBOTVicarious Surgical--

NXL Revenue FAQ


What is Nexalin’s yearly revenue?

Nexalin's yearly revenue for 2025 was $301.65K, representing an increase of 78.78% compared to 2024. The company's yearly revenue for 2024 was $168.72K, representing an increase of 52.35% compared to 2023. NXL's yearly revenue for 2023 was $110.75K, representing a decrease of -91.62% compared to 2022.

What is Nexalin’s quarterly revenue?

Nexalin's quarterly revenue for Q3 2025 was $18.15K, a -74.29% decrease from the previous quarter (Q2 2025), and a -49.63% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $70.59K, a 72.10% increase from the previous quarter (Q1 2025), and a 163.00% increase year-over-year (Q2 2024). NXL's quarterly revenue for Q1 2025 was $41.02K, a 50.91% increase from the previous quarter (Q4 2024), and a -47.87% decrease year-over-year (Q1 2024).

What is Nexalin’s revenue growth rate?

Nexalin's revenue growth rate for the last 3 years (2023-2025) was 172.37%, and for the last 5 years (2021-2025) was 109.38%.

What are Nexalin’s revenue streams?

Nexalin's revenue streams in c 25 are Device Sales, Equipment, Licensing Fee, and Other. Device Sales generated $136K in revenue, accounting 45.09% of the company's total revenue, up 145.05% year-over-year. Equipment generated $89.04K in revenue, accounting 29.52% of the company's total revenue, up 135.40% year-over-year. Licensing Fee generated $49.11K in revenue, accounting 16.28% of the company's total revenue, down -29.33% year-over-year. Other generated $27.49K in revenue, accounting 9.11% of the company's total revenue, up 366.42% year-over-year.

What is Nexalin’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Nexalin was Device Sales. This segment made a revenue of $136K, representing 45.09% of the company's total revenue.